Figure 1 from Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers: Implications for HER2-Targeted Therapies
<p><b>A</b> and <b>B,</b> Representative micrographs of HER2 IHC staining in prostate cancer (<b>A</b>) and urothelial cancer (<b>B</b>) autopsy specimens. <b>C,</b> Number of patients with at least one tumor with the indicated HER2 IHC score, color coded by cancer type. <b>D,</b> Number of tumors across all patients with the indicated HER2 IHC score, color coded by cancer type. <b>E</b> and <b>F,</b> Percent of tumors expressing the indicated level of HER2 staining by IHC according to the tumor site sampled in prostate (<b>E</b>) and urothelial (<b>F</b>) cancer cohorts. Anatomic sites with only one representative tumor were excluded. PC, prostate cancer; UC, urothelial carcinoma.</p>
Authors
- Andrew Caleb Hsieh (ORCID: https://orcid.org/0000-0002-0897-1050)
- Maria Tretiakova (ORCID: https://orcid.org/0000-0002-0819-9638)
- Jessica E. Hawley (ORCID: https://orcid.org/0000-0003-1720-5654)
- Colm M. Morrissey (ORCID: https://orcid.org/0000-0003-1906-5333)
- Michael Thomas Schweizer (ORCID: https://orcid.org/0000-0002-5510-0661)
- Hung‐Ming Lam (ORCID: https://orcid.org/0000-0001-8921-6091)
- Radhika A. Patel (ORCID: https://orcid.org/0009-0008-4889-6818)
- Farinaz Shokri
- Erolcan Sayar (ORCID: https://orcid.org/0000-0002-3922-5683)
- Samantha L. Schuster (ORCID: https://orcid.org/0000-0003-4051-5802)
- Petros D. Grivas (ORCID: https://orcid.org/0000-0003-3965-3394)
- Meagan Chambers (ORCID: https://orcid.org/0000-0002-8741-0509)
- Lawrence D. True (ORCID: https://orcid.org/0000-0002-8621-9569)
- Gavin Ha (ORCID: https://orcid.org/0000-0001-7578-7272)
- Roman Gulati (ORCID: https://orcid.org/0000-0002-7592-6567)
- Heather H. Cheng (ORCID: https://orcid.org/0000-0002-1365-0702)
- Bruce Montgomery (ORCID: https://orcid.org/0000-0003-4459-0295)
- Funda Vakar‐Lopez
- Michael C. Haffner (ORCID: https://orcid.org/0000-0003-0809-6425)
- Peter S. Nelson (ORCID: https://orcid.org/0000-0002-5451-5726)
- Ruben Raychaudhuri (ORCID: https://orcid.org/0000-0001-6587-4954)
- Ilsa M. Coleman (ORCID: https://orcid.org/0000-0002-1483-7202)
- Jonathan Lawrence Wright (ORCID: https://orcid.org/0000-0002-8447-8209)
- Evan Y. Yu (ORCID: https://orcid.org/0000-0002-1510-8044)
- Pushpa Itagi
- Sonali Arora (ORCID: https://orcid.org/0000-0002-6661-3024)
- Mohamed Adil (ORCID: https://orcid.org/0000-0003-1787-644X)
- Thomas Persse (ORCID: https://orcid.org/0009-0000-3209-592X)
- Hyun Jung Lee (ORCID: https://orcid.org/0000-0002-2995-6060)
- Helen Richards (ORCID: https://orcid.org/0009-0008-4328-488X)
Publication Details
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1158/2767-9764.29978438
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00